Sophiris Bio Inc.

Oct 02, 2017

Sophiris Bio Provides Enrollment Update on Topsalysin Phase 2b Study in Localized Prostate Cancer

Sep 13, 2017

Sophiris Bio Secures up to $10 Million in Term Loans from Silicon Valley Bank

Aug 17, 2017

Sophiris Bio to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

Aug 10, 2017

Sophiris Bio Reports Second Quarter Financial Results and Key Corporate Highlights

Jun 23, 2017

Sophiris Bio Added to Russell Microcap Index

Jun 08, 2017

Sophiris Bio Announces that the First Patient Has Been Dosed in Phase 2b Study of Topsalysin in Patients with Clinically Significant Localized Prostate Cancer